Article

Lipid Accumulation Product: An Obtainable and Accurate Marker for Predicting Metabolic Syndrome in Kidney Transplant Recipients

2021-07-01

Abstract excerpt

<title>Abstract</title> <p>Background Metabolic syndrome (MS) is common in kidney transplant recipients(KTRs) and associated with an increased risk of cardiovascular events. There is a need for accurate, non-invasive methods to predict MS in this population. Lipid accumulation product (LAP) is an effective marker of central lipid accumulation related to high risk of MS, cardiovascular disease(CVD) and diabetes....

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 83af4438-c031-5c27-931c-e73d890a84b2
DOI: 10.21203/rs.3.rs-616369/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Lipid Accumulation Product: An Obtainable and Accurate Marker for Predicting Metabolic Syndrome in Kidney Transplant RecipientsDOI 10.21203/rs.3.rs-616369/v1Read

Comparison of Novel Metabolic Indices in Estimation of Chronic Kidney Diseases in a Southern Chinese PopulationSemantic proximity Read

Lipid accumulation product as a marker of cardiometabolic susceptibility in women with different phenotypes of polycystic ovary syndrome.Semantic proximity Read

Visceral Adiposity Index and Lipid Accumulation Product as Effective Markers of Different Obesity Phenotypes in Korean Adults: A Cross-Sectional AnalysisSemantic proximity Read

Evaluation of adiposity phenotypes: lipid accumulation product index, visceral adipose index and body roundness index as predictor markers for metabolic syndrome development in type 2 diabetes mellitusSemantic proximity Read

Comparison of the Association and Predictive Ability of Anthropometric Indexes for Metabolic Syndrome in Chinese AdultsSemantic proximity Read

Associations of the triglyceride–glucose index, triglyceride glucose–body mass index and waist–triglyceride index with mortality in patients with cardiovascular–kidney–metabolic syndrome stages 0-4: evidence from NHANES 1999-2020Semantic proximity Read

Is UA/HDL-C a Reliable Surrogate Marker for Fatty Liver? A Comparative Evaluation with Metabolic Scores in a Mexican Population: The Genetics of Atherosclerotic Disease StudySemantic proximity Read

Body adiposity index, lipid accumulation product, and cardiometabolic index reveal the contribution of adiposity phenotypes in the risk of hyperuricemia among Chinese rural population.Semantic proximity Read

Sphingolipid Profiling: A Promising Tool for Stratifying the Metabolic Syndrome-Associated RiskSemantic proximity Read

Molecular mechanisms of disorders of lipid metabolism in chronic kidney disease.Semantic proximity Read

Risk prediction of the metabolic syndrome using TyG Index and SNPs: a 10-year longitudinal prospective cohort study.Semantic proximity Read

Novel metabolic risk markers in obesity and type two diabetes mellitusSemantic proximity Read